本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

66.17
-1.3400-1.98%
盤後66.170.00000.00%19:30 EDT
成交量:114.98萬
成交額:7,694.43萬
市值:62.37億
市盈率:-138.88
高:68.73
開:67.76
低:66.11
收:67.51
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.91
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:254.35
市盈率(LYR):-231.08

資料載入中...

2023/03/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/03/01

重要事件披露

8-K - Current report
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/10/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/27

重要事件披露

8-K - Current report
2022/10/27

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/13

重要事件披露

8-K - Current report
2022/08/22

重要事件披露

8-K - Current report
2022/08/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/17

重要事件披露

8-K/A [Amend] - Current report